Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning

Journal of Surgical Research

Volumn 92, Issue 1, 2000, Pages 114-119

  Patel, Kepal N ^a   Weiss, Harvey R ^b   Scholz, Peter M ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cyclic GMP; Guanylate cyclase; Ischemia; Myocardial stunning; Nitric oxide; O2 consumption; ODQ; Reperfusion

Indexed keywords

CYCLIC GMP;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; INOTROPISM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; METABOLIC REGULATION; MICROSPECTROPHOTOMETRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STUNNED HEART MUSCLE;

EID: 0034234549     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5944     Document Type: Article

References (35)

1. Chiu W. C., Kedem J., Scholz P. M., Weiss H. R. Regional asynchrony of segmental contraction may explain the "oxygen consumption paradox" in stunned myocardium. Basic Res. Cardiol. 89:1994;149.
2. Stahl L. D., Weiss H. R., Becker L. C. Myocardial oxygen consumption, oxygen supply/demand heterogeneity, and microvascular patency in regionally stunned myocardium. Circ. 77:1988;865.
3. Acad B. A., Weiss H. R. Regional oxygen consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium. J. Pharmacol. Exp. Ther. 250:1989;611.
4. Ambrosio G., Jacobus W., Bergman C. A., Weisman H. F., Becker L. C. Preserved high energy phosphate metabolic reserve in globally "stunned" heart despite reduction of basal ATP content and contractility. J. Mol. Cell Cardiol. 219:1987;953.
5. Joselevitz-Goldman J., Upsher M. E., Weiss H. R. Effects of propranolol on regional oxygen supply and oxygen consumption in reperfused dog myocardium. J. Pharmacol. Exp. Ther. 242:1990;102.
6. Liedtke A. J., DeMainson L., Eggleston A. M., Cohen L. M., Nellis S. H. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ. Res. 62:1988;535.
7. Dean E. N., Shlafer M., Nicklas J. M. The oxygen consumption paradox of "stunned myocardium" in dogs. Basic Res. Cardiol. 85:1987;120.
8. Ito B. R., Tate H., Kobayashi M., Schaper W. Reversible injured, postischemic canine myocardium retains normal contractile reserve. Circ. Res. 61:1987;834.
9. Heusch G., Schafer S., Kroger K. Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57. Basic Res. Cardiol. 83:1988;602.
10. Brady A. B., Warren J. B., Poole-Wilson P., Williams T., Harding S. E. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265:1993;H176.
11. Roitstein A., Kedem J., Cheinberg B., Weiss H. R., Tse J., Scholz P. M. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. J. Surg. Res. 57:1994;584.
12. Shah A. J., Spurgeon H. A., Sollott S. J., Talo A., Lakatta E. G. 8-Bromo-cGMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ. Res. 74:1994;970.
13. Maulik N., Engelman D. T., Watanabe M., Engelman R. M., Maulik G., Cordis G. A., Das D. K. Nitric oxide signaling in ischemic heart. Cardiovasc. Res. 30:1995;593.
14. Maulik N., Engelman D. T., Watanabe M., Engelman R. M., Rousou J. A., Flack J. E., Deaton D. W., Gorbunov N. V., Elsayed N. M., Kagan V. E., Das D. K. Nitric oxide/carbon monoxide: A molecular switch for myocardial preservation during ischemia. Circulation. 94:1996;II398.
15. Matheis G., Sherman M. P., Buckberg G. D., Hayborn D. M., Young H. H., Ignarro L. J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262:1992;H616.
16. Mori E., Haramaki N., Ikeda H., Imaizumi T. Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc. Res. 40:1998;113.
17. Weiss H. R., Sinha A. K. Regional oxygen saturation of small arteries and veins in the canine myocardium. Circ. Res. 42:1978;119.
18. Zhu N. H., Weiss H. R. Oxy- and carboxyhemoglobin saturation determination in frozen small vessels. Am. J. Physiol. 260:1991;H626.
19. Kusuoka H., Marban E. Cellular mechanisms of myocardial stunning. Annu. Rev. Physiol. 54:1992;243.
20. Hess H. L., Kukreja R. C. Myocardial stunning. J. Card. Surg. 9:1994;382.
21. Schulz R., Ehring T., Heusch G. Stunned myocardium: inotropic reserve and pharmacological attenuation. Bas. Res. Cardiol. 90:1995;294.
22. Becker L. C., Levine J. H., DiPaula A. F., Guarnieri T., Aversano T. Reversal of dysfunction in post-ischemic stunned myocardium by epinephrine and post-extrasystolic potentiation. J. Am. Coll. Cardiol. 7:1986;580.
23. Bolli R., Zhu W., Myers M. L., Hartley C. J., Roberts R. Beta-adrenergic stimulation reverses post-ischemic myocardial dysfunction without producing subsequent functional deterioration. Am. J. Cardiol. 56:1985;964.
24. Kedem J., Sonn J., Scheinowitz M., Weiss H. R. Effect of isoproterenol on regional myocardial segment work, oxygen consumption and oxygen balance. Res. Exp. Med. 192:1992;323.
25. Balligand J., Kelly R., Marsden P. A., Smith T. W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA. 90:1993;347.
26. Lohmann S. M., Fischmeister R., Walter U. Signal transduction by cGMP in heart. Basic Res. Cardiol. 86:1991;503.
27. Morgan H. E. Cellular aspects of cardiac failure. Circulation. 87:1993;IV4.
28. Mery P. F., Lohmann S. M., Walter U., Fischmeister R. Calcium current is regulated by cGMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA. 88:1991;1197.
29. Ono K., Trautwein W. Potentiation by cGMP of beta-adrenergic effect on calcium current in guinea-pig ventricular cells. J. Physiol. 443:1991;387.
30. Xie Y. W., Shen W., Zhao G., Xu X., Wolin M. S., Hintze T. H. Role of endothelium derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ. Res. 79:1996;381.
31. Loke K. E., McConnell P. I., Tuzman T. M., Shesely E. G., Smith C. J., Stackpole C. T., Thompson C. I., Kaley G., Wolin M. S., Hintze T. H. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ. Res. 84:1999;840.
32. Naim K. L., Weiss H. R., Guo X., Sadoff J., Scholz P. M., Kedem J. Local inotropic stimulation by methylene blue does not improve mechanical dysfunction due to myocardial stunning. Res. Exp. Med. 197:1997;23.
33. Ehring T., Baumgart D., Krajear M., Hummelgen M., Kompa S., Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation. 90:1994;1368.
34. Sadoff J. D., Scholz P. M., Weiss H. R. Endogenous basal nitric oxide production does not control myocardial oxygen consumption or function. Proc. Soc. Exp. Biol. Med. 211:1996;332-338.
35. Gandhi A., Yan L., Scholz P. M., Huang M. W., Weiss H. R. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion. Nitric Oxide. 3:1999;473.